BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6350776)

  • 1. The immunopharmacology of antileprosy agents.
    Anderson R
    Lepr Rev; 1983 Jun; 54(2):139-44. PubMed ID: 6350776
    [No Abstract]   [Full Text] [Related]  

  • 2. A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.
    Matsuoka M; Kashiwabara Y; Namisato M
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):452-5. PubMed ID: 11332288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dapsone drug resistance in the MDT era.
    Roche PW; Neupane KD; Failbus SS; Butlin CR
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro and in vivo interactions of drugs used in multidrug therapy in leprosy.
    Dhople AM; Lamoureux LC; Gardner GD
    Indian J Lepr; 1991; 63(2):166-79. PubMed ID: 1664440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism and interactions of antileprosy drugs.
    George J
    Biochem Pharmacol; 2020 Jul; 177():113993. PubMed ID: 32339493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of constituents of MDT regimen for leprosy with Mycobacterium leprae HSP18: impact on its structure and function.
    Chakraborty A; Ghosh R; Biswas A
    FEBS J; 2022 Feb; 289(3):832-853. PubMed ID: 34555271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An attempt to induce a histological ENL symptom in M. leprae infected nude mice.
    Subowo
    Nihon Rai Gakkai Zasshi; 1986; 55(4):173-85. PubMed ID: 3323158
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug resistance in leprosy: lessons from past and future perspective.
    Gupta UD; Katoch VM
    Indian J Lepr; 1999; 71(4):451-63. PubMed ID: 10804973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India.
    Ebenezer GJ; Norman G; Joseph GA; Daniel S; Job CK
    Indian J Lepr; 2002; 74(4):301-12. PubMed ID: 12624978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of cell mediated immunity in leprosy.
    Dubey GK; Joglekar VK; Hardas UD; Chaubey BS
    Lepr India; 1981 Apr; 53(2):197-203. PubMed ID: 7253571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concepts behind the development of multiple drug therapy regimens in leprosy.
    Waters MF
    Lepr Rev; 1986 Dec; 57 Suppl 1():61-7. PubMed ID: 3295437
    [No Abstract]   [Full Text] [Related]  

  • 12. Study of antileprosy activities of some dialkyldithiocarbamate derivatives.
    Urlyapova NG; Yushchenko AA; Daudova AD; Makarov VA
    Bull Exp Biol Med; 2007 Mar; 143(3):356-8. PubMed ID: 18225763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term evaluation of immune status in leprosy patients undergoing multiple drug therapy.
    Vu TT; Hoang TL; Nguyen DQ; Ho ML; Nguyen DH; Le TH; Dang DT; Nguyen QA; Le TP; Tran HK
    Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):365-73. PubMed ID: 7963908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative characterization of the antigenic composition of M. leprae and M. lufu].
    Salamatina OS; Diachina MN; Iushchenko AA; Chernousova LN; Kalinina ON; Parshin MP
    Probl Tuberk; 2001; (8):49-51. PubMed ID: 11767394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clofazimine modulates the expression of lipid metabolism proteins in Mycobacterium leprae-infected macrophages.
    Degang Y; Akama T; Hara T; Tanigawa K; Ishido Y; Gidoh M; Makino M; Ishii N; Suzuki K
    PLoS Negl Trop Dis; 2012; 6(12):e1936. PubMed ID: 23236531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of immune reactions in leprosy.
    Harboe M
    Ethiop Med J; 1976 Oct; 14(4):205-12. PubMed ID: 799966
    [No Abstract]   [Full Text] [Related]  

  • 17. The response to chemotherapy of serum Mycobacterium leprae-specific antigen in multibacillary leprosy patients.
    Roche PW; Britton WJ; Neupane KD; Failbus SS; Cho SN; Theuvenet WJ
    Am J Trop Med Hyg; 1991 Jun; 44(6):702-8. PubMed ID: 1858971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug-resistance to dapsone, rifampicin, and ofloxacin in Mycobacterium leprae.
    Cambau E; Perani E; Guillemin I; Jamet P; Ji B
    Lancet; 1997 Jan; 349(9045):103-4. PubMed ID: 8996430
    [No Abstract]   [Full Text] [Related]  

  • 19. Multidrug therapy (MDT) and leprosy control.
    Noordeen SK
    Indian J Lepr; 1990; 62(4):448-58. PubMed ID: 2086680
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent trends in chemotherapy of leprosy.
    Parikh DA; Maniar JK; Parikh AC; Ganapati R
    J Assoc Physicians India; 1985 Sep; 33(9):593-5. PubMed ID: 3912375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.